Literature DB >> 27756179

An overview of the mechanisms and novel roles of Nrf2 in cardiovascular diseases.

Shuai Jiang1,2, Yang Yang3,4, Tian Li3, Zhiqiang Ma5, Wei Hu3, Chao Deng1, Chongxi Fan5, Jianjun Lv3, Yang Sun6, Wei Yi1.   

Abstract

INTRODUCTION: Nuclear factor erythroid 2-related factor 2 (Nrf2) is a basic leucine zipper (bZIP) transcription factor of the cap'n'collar (CNC) family that is present in various organs. The cardiovascular system (CVS) is susceptible to a spectrum of diseases that are strongly associated with increased risks of mortality and morbidity, and studies have demonstrated that Nrf2 has a pivotal role in protection against cardiovascular diseases (CVDs). Areas covered: Nrf2 is a basic protective molecule that guards against CVD by attenuating oxidative stress, mitochondrial dysfunction, and inflammation. Initially, we briefly introduce the biological characteristics of Nrf2 and the newly discovered Neh7 domain. Next, we discuss the concrete roles of Nrf2 in the CVS and enumerate some related upstream molecules and downstream targets. Lastly, we expand our focus to the behaviors of Nrf2 in CVDs and discuss potential research directions. Expert opinion: Although certain studies have cast doubt on the positive actions of Nrf2 in the CVS, Nrf2 is a pivotal endogenous molecule for defense against CVD. The review compiled here may serve as a broad and comprehensive reference for the roles of Nrf2 in the CVS, with the aim of facilitating the design of new drugs and clinical therapies for CVDs.

Entities:  

Keywords:  Nuclear factor erythroid 2-related factor 2; cardiovascular system; oxidative stress; potential research directions

Mesh:

Substances:

Year:  2016        PMID: 27756179     DOI: 10.1080/14728222.2016.1250887

Source DB:  PubMed          Journal:  Expert Opin Ther Targets        ISSN: 1472-8222            Impact factor:   6.902


  11 in total

1.  NRF2 prevents hypertension, increased ADMA, microvascular oxidative stress, and dysfunction in mice with two weeks of ANG II infusion.

Authors:  Cheng Wang; Zaiming Luo; Gabriella Carter; Anton Wellstein; Pedro A Jose; James Tomlinson; James Leiper; William J Welch; Christopher S Wilcox; Dan Wang
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2017-11-22       Impact factor: 3.619

Review 2.  Melatonin: does it have utility in the treatment of haematological neoplasms?

Authors:  Tian Li; Zhi Yang; Shuai Jiang; Wencheng Di; Zhiqiang Ma; Wei Hu; Fulin Chen; Russel J Reiter; Yang Yang
Journal:  Br J Pharmacol       Date:  2017-09-09       Impact factor: 8.739

3.  Differential Site-Based Expression of Pentose Phosphate Pathway-Related Proteins among Breast Cancer Metastases.

Authors:  Yoon Jin Cha; Woo Hee Jung; Ja Seung Koo
Journal:  Dis Markers       Date:  2017-02-02       Impact factor: 3.434

4.  KRIT1 loss-of-function induces a chronic Nrf2-mediated adaptive homeostasis that sensitizes cells to oxidative stress: Implication for Cerebral Cavernous Malformation disease.

Authors:  Cinzia Antognelli; Eliana Trapani; Simona Delle Monache; Andrea Perrelli; Martina Daga; Stefania Pizzimenti; Giuseppina Barrera; Paola Cassoni; Adriano Angelucci; Lorenza Trabalzini; Vincenzo Nicola Talesa; Luca Goitre; Saverio Francesco Retta
Journal:  Free Radic Biol Med       Date:  2017-11-21       Impact factor: 7.376

5.  Nrf2-dependent antioxidant response mediated the protective effect of tanshinone IIA on doxorubicin-induced cardiotoxicity.

Authors:  Zhaohui Guo; Miao Yan; Lei Chen; Pingfei Fang; Zhihua Li; Zimeng Wan; Sisi Cao; Zhenyan Hou; Shanshan Wei; Wenqun Li; Bikui Zhang
Journal:  Exp Ther Med       Date:  2018-08-17       Impact factor: 2.447

6.  Buyang Huanwu Decoction Enhances Revascularization via Akt/GSK3β/NRF2 Pathway in Diabetic Hindlimb Ischemia.

Authors:  Xiao-Yi Bao; Li-Hui Deng; Zi-Jun Huang; Abdirizak S Daror; Zi-Hao Wang; Wang-Jun Jin; Zhuang Zhuang; Qiang Tong; Guo-Qing Zheng; Yan Wang
Journal:  Oxid Med Cell Longev       Date:  2021-12-03       Impact factor: 6.543

Review 7.  The Role of NRF2 in Obesity-Associated Cardiovascular Risk Factors.

Authors:  Jorge Gutiérrez-Cuevas; Marina Galicia-Moreno; Hugo Christian Monroy-Ramírez; Ana Sandoval-Rodriguez; Jesús García-Bañuelos; Arturo Santos; Juan Armendariz-Borunda
Journal:  Antioxidants (Basel)       Date:  2022-01-26

8.  Trimetazidine and exercise offer analogous improvements to the skeletal muscle insulin resistance of mice through Nrf2 signaling.

Authors:  Wenliang Zhang; Yaoshan Dun; Baiyang You; Ling Qiu; Jeffrey W Ripley-Gonzalez; Jing Cheng; Siqian Fu; Cui Li; Suixin Liu
Journal:  BMJ Open Diabetes Res Care       Date:  2022-03

9.  Treatment with 5-fluoro-2-oxindole Increases the Antinociceptive Effects of Morphine and Inhibits Neuropathic Pain.

Authors:  Pablo Ferreira-Chamorro; Alejandro Redondo; Gabriela Riego; Olga Pol
Journal:  Cell Mol Neurobiol       Date:  2020-09-02       Impact factor: 5.046

10.  AMPK: a novel target for treating hepatic fibrosis.

Authors:  Zhenxing Liang; Tian Li; Shuai Jiang; Jing Xu; Wencheng Di; Zhi Yang; Wei Hu; Yang Yang
Journal:  Oncotarget       Date:  2017-07-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.